CAP Pilot Study for Obstructive Sleep Apnea (OSA)
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Other: CAP
- Registration Number
- NCT02309749
- Lead Sponsor
- Fisher and Paykel Healthcare
- Brief Summary
This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours per night.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Not provided
- Contraindicated for CPAP therapy
- Medically unstable condition/diagnosis that is not yet under control
- Co-existing sleep disorder (however clinically diagnosed insomnia can be included in the study)
- Periodic Leg MOvement Arousal Index greater than 15/hr
- Home titration of longer than 5 days
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Naive cohort CAP -
- Primary Outcome Measures
Name Time Method Accuracy of delivery of SMS messages to participant 30 days Cross check recieved messages logged in a diary by the participant to those sent by CAP
- Secondary Outcome Measures
Name Time Method Participant CPAP Adherence 30 nights Assess the adherence of participants to CPAP therapy while enrolled in CAP
Trial Locations
- Locations (2)
Clayton Sleep Institute
🇺🇸St Louis, Missouri, United States
Sleep Therapy Research Center
🇺🇸San Antonio, Texas, United States